+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pets Anti-infective Drugs Market - Global Forecast 2026-2032- Product Image
Pets Anti-infective Drugs Market - Global Forecast 2026-2032- Product Image
Sale

Pets Anti-infective Drugs Market - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6123178
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Pets Anti-infective Drugs Market is projected to reach USD 1.10 Billion in 2026. It is expected to continue growing at a CAGR of 6.74%, reaching USD 1.65 Billion by 2032.

Pets Anti-infective Drugs: Executive Overview

Pets anti-infective drugs encompass therapies used to prevent or treat bacterial, viral, fungal, and parasitic infections in companion animals. Demand is shaped by veterinary access, diagnostic capability, antimicrobial stewardship, regulatory oversight, pet ownership patterns, and the growing emphasis on animal welfare. Clinical use spans routine infections, surgical care, chronic conditions, and urgent treatment, with product selection increasingly influenced by pathogen identification and patient-specific risk factors.

How Stewardship and Veterinary Practice Are Reshaping Treatment

The landscape is shifting from empirical treatment toward more targeted prescribing. Veterinary professionals are placing greater emphasis on diagnostic testing, appropriate dose and duration, infection prevention, and treatment documentation. Regulatory scrutiny of antimicrobial use, concern about resistance, improved veterinary infrastructure, and rising expectations for companion-animal care are encouraging safer administration and closer clinical monitoring. Access remains uneven, particularly where diagnostics, trained personnel, and reliable medicine distribution are limited.

Artificial Intelligence Strengthens Diagnosis, Surveillance, and Drug Stewardship

Artificial intelligence can support the field by identifying patterns in clinical records, improving interpretation of diagnostic images and laboratory results, and helping veterinarians prioritize differential diagnoses. Predictive tools may also assist antimicrobial stewardship through resistance surveillance, treatment-response monitoring, and identification of patients at higher risk of complications. These applications require representative veterinary data, clinical validation, transparent decision support, privacy safeguards, and human oversight; AI should complement rather than replace professional diagnosis and prescribing.

Regional Differences Reflect Uneven Veterinary Access and Stewardship Capacity

North America generally combines advanced companion-animal practice, broad diagnostic availability, and strong regulatory attention to responsible antimicrobial use. Europe emphasizes stewardship, prescription governance, and harmonized veterinary standards, while variation persists across national systems. Asia-Pacific includes sophisticated urban veterinary markets alongside areas where access and diagnostics are developing. Latin America is influenced by expanding pet care, uneven distribution networks, and differing regulatory enforcement. The Middle East shows concentrated demand around major urban and referral centers, with import dependence affecting availability in some settings. Africa presents substantial unmet needs linked to veterinary workforce distribution, affordability, diagnostics, and medicine access, while also requiring stronger surveillance of resistance and counterfeit or substandard products.

Economic and Policy Groups Reveal Distinct Adoption Conditions

ASEAN markets reflect varied regulatory systems, urbanization, and veterinary infrastructure, making regional coordination valuable for stewardship and supply reliability. BRICS members combine large and diverse animal-health ecosystems with differing access, manufacturing capabilities, and enforcement approaches. The European Union benefits from shared regulatory structures and coordinated antimicrobial-resistance priorities. G7 countries generally have mature veterinary services, established pharmacovigilance practices, and stronger diagnostic capacity. GCC markets are characterized by high urban concentration, import exposure, and advanced private healthcare segments, while NATO countries span highly developed and emerging systems with differing military, civil, and veterinary public-health priorities.

Country Conditions Range from Mature Clinical Systems to Access-Limited Environments

Australia combines established veterinary services with geographic access challenges. Brazil has a large companion-animal population and varied regional infrastructure. Canada and the United States have sophisticated clinical networks alongside continuing stewardship and access considerations. China is expanding veterinary capacity while navigating regulatory standardization across a large system. France, Germany, Italy, and Spain operate within European stewardship priorities, with national differences in prescribing and reimbursement practices. India faces major diversity in access, affordability, and diagnostic availability. Japan and South Korea have advanced urban veterinary care and strong technology adoption. Mexico is supported by growing pet-care demand but exhibits regional variation in service access. Russia’s veterinary supply and regulatory environment are shaped by domestic production, import conditions, and geographic scale. The United Kingdom maintains established veterinary oversight with continued attention to responsible prescribing.

Prioritize Diagnostics, Stewardship, Resilience, and Clinician-Centered Innovation

Industry leaders should align product development with clearly defined pathogens, species-specific safety, and evidence-based dosing. Investment in rapid diagnostics, susceptibility testing, treatment adherence tools, and post-treatment monitoring can support more precise care. Organizations should strengthen pharmacovigilance, educational partnerships with veterinary professionals, and transparent stewardship metrics. Supply strategies should account for regional regulatory requirements, cold-chain or storage needs, counterfeit risk, and continuity of essential products. Digital and AI-enabled tools should be introduced through validated workflows, with clear accountability, explainable outputs, and safeguards for clinical data.

Methodology for a Evidence-Based Executive Assessment

This executive summary applies a structured qualitative framework to the defined pets anti-infective drugs category. It considers therapeutic scope, veterinary practice, antimicrobial resistance, diagnostics, regulation, access, supply conditions, technology adoption, and animal-health policy. Regional, group, and country observations are synthesized from established public-health and veterinary principles rather than unsupported commercial claims. The assessment intentionally excludes market estimates, market shares, forecasts, and company-specific analysis, and should be supplemented with current regulatory, epidemiological, and clinical evidence for operational decisions.

Responsible Use Will Define the Next Phase of Companion-Animal Anti-infective Care

The category is being shaped by the intersection of rising expectations for companion-animal health, antimicrobial-resistance concerns, uneven veterinary access, and faster digital innovation. Durable progress will depend on combining reliable medicines with accurate diagnosis, responsible prescribing, surveillance, professional education, and resilient distribution. Leaders that integrate clinical evidence, regional realities, and accountable technology practices will be better positioned to improve treatment quality while protecting the long-term effectiveness of anti-infective therapies.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Pets Anti-infective Drugs Market, by Drug Class
7.1. Introduction
7.2. Antibiotics
7.2.1. Aminoglycosides
7.2.2. Beta-Lactams
7.2.3. Macrolides
7.2.4. Tetracyclines
7.3. Antifungals
7.3.1. Azoles
7.3.2. Polyenes
7.4. Antiparasitics
7.4.1. Anticoccidials
7.4.2. Endectocides
7.5. Antivirals
8. Pets Anti-infective Drugs Market, by Animal Type
8.1. Introduction
8.2. Cats
8.3. Dogs
8.4. Horses
8.5. Small Mammals
8.5.1. Rabbits
8.5.2. Rodents
9. Pets Anti-infective Drugs Market, by Route Of Administration
9.1. Introduction
9.2. Oral
9.3. Parenteral
9.3.1. Intramuscular
9.3.2. Intravenous
9.3.3. Subcutaneous
9.4. Topical
10. Pets Anti-infective Drugs Market, by Distribution Channel
10.1. Introduction
10.2. Online Retailers
10.3. Retail Pharmacies
10.4. Veterinary Hospitals
10.5. Veterinary Pharmacies
11. Pets Anti-infective Drugs Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Pets Anti-infective Drugs Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Pets Anti-infective Drugs Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Bayer Animal Health
15.2. Bimeda Animal Health
15.3. Boehringer Ingelheim Animal Health
15.4. Cargill Inc.
15.5. Ceva Santé Animale
15.6. China Animal Healthcare Ltd.
15.7. China Animal Husbandry Industry Corporation
15.8. Dechra Pharmaceuticals PLC
15.9. Elanco Animal Health Incorporated
15.10. Evonik Industries AG
15.11. Guangdong Wens Dahuanong Biotechnology Co. Ltd.
15.12. Hester Biosciences Ltd.
15.13. Huvepharma
15.14. IDEXX Laboratories, Inc.
15.15. Intas Pharmaceuticals
15.16. Kyoritsu Seiyaku Corporation
15.17. Merck Animal Health
15.18. Nippon Zenyaku Kogyo Co., Ltd.
15.19. Norbrook Laboratories
15.20. Nutreco N.V.
15.21. Phibro Animal Health Corporation
15.22. Prodivet Pharmaceuticals SA/NV
15.23. Vetoquinol S.A.
15.24. Virbac S.A.
15.25. Zoetis Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Pets Anti-infective Drugs Market, Years Considered for the Study
FIGURE 2. Global Pets Anti-infective Drugs Market, Research Design
FIGURE 3. Global Pets Anti-infective Drugs Market, Research Framework
FIGURE 4. Global Pets Anti-infective Drugs Market, Data Triangulation
FIGURE 5. Global Pets Anti-infective Drugs Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Pets Anti-infective Drugs Market Size, by Drug Class, 2025 vs 2032 (%)
FIGURE 7. Global Pets Anti-infective Drugs Market Size, by Drug Class, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Pets Anti-infective Drugs Market Size, by Animal Type, 2025 vs 2032 (%)
FIGURE 9. Global Pets Anti-infective Drugs Market Size, by Animal Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Pets Anti-infective Drugs Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 11. Global Pets Anti-infective Drugs Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Pets Anti-infective Drugs Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Pets Anti-infective Drugs Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Pets Anti-infective Drugs Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Pets Anti-infective Drugs Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Pets Anti-infective Drugs Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Pets Anti-infective Drugs Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Pets Anti-infective Drugs Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Pets Anti-infective Drugs Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Pets Anti-infective Drugs Market Segmentation & Coverage
TABLE 2. Global Pets Anti-infective Drugs Market Size, 2017-2032 (USD Million)
TABLE 3. Global Pets Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 4. Global Antibiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Antibiotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Antibiotics Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Aminoglycosides Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Aminoglycosides Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Aminoglycosides Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Beta-Lactams Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Beta-Lactams Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Beta-Lactams Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Macrolides Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Macrolides Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Macrolides Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Tetracyclines Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Tetracyclines Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Tetracyclines Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Antifungals Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Antifungals Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Antifungals Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Azoles Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Azoles Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Azoles Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Polyenes Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Polyenes Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Polyenes Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Antiparasitics Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Antiparasitics Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Antiparasitics Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Anticoccidials Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Anticoccidials Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Anticoccidials Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Endectocides Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Endectocides Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Endectocides Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Antivirals Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Antivirals Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Antivirals Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Pets Anti-infective Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 41. Global Cats Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Cats Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Cats Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Dogs Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Dogs Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Dogs Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Horses Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Horses Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Horses Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Small Mammals Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Small Mammals Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Small Mammals Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Rabbits Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Rabbits Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Rabbits Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Rodents Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Rodents Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Rodents Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Pets Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 60. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Parenteral Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Parenteral Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Parenteral Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Intramuscular Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Intramuscular Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Intramuscular Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Intravenous Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Intravenous Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Intravenous Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Subcutaneous Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Subcutaneous Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Subcutaneous Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Topical Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Topical Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Topical Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Pets Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 79. Global Online Retailers Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Online Retailers Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Online Retailers Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Veterinary Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Veterinary Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Veterinary Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Veterinary Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Veterinary Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Veterinary Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Pets Anti-infective Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Asia-Pacific Pets Anti-infective Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Asia-Pacific Pets Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 94. Asia-Pacific Pets Anti-infective Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 95. Asia-Pacific Pets Anti-infective Drugs Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific Pets Anti-infective Drugs Market Size, by Antiparasitics, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific Pets Anti-infective Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 98. Asia-Pacific Pets Anti-infective Drugs Market Size, by Small Mammals, 2017-2032 (USD Million)
TABLE 99. Asia-Pacific Pets Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 100. Asia-Pacific Pets Anti-infective Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 101. Asia-Pacific Pets Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 102. North America Pets Anti-infective Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. North America Pets Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 104. North America Pets Anti-infective Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 105. North America Pets Anti-infective Drugs Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 106. North America Pets Anti-infective Drugs Market Size, by Antiparasitics, 2017-2032 (USD Million)
TABLE 107. North America Pets Anti-infective Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 108. North America Pets Anti-infective Drugs Market Size, by Small Mammals, 2017-2032 (USD Million)
TABLE 109. North America Pets Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 110. North America Pets Anti-infective Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 111. North America Pets Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 112. Latin America Pets Anti-infective Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Latin America Pets Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 114. Latin America Pets Anti-infective Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 115. Latin America Pets Anti-infective Drugs Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 116. Latin America Pets Anti-infective Drugs Market Size, by Antiparasitics, 2017-2032 (USD Million)
TABLE 117. Latin America Pets Anti-infective Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 118. Latin America Pets Anti-infective Drugs Market Size, by Small Mammals, 2017-2032 (USD Million)
TABLE 119. Latin America Pets Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 120. Latin America Pets Anti-infective Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 121. Latin America Pets Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 122. Europe Pets Anti-infective Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Europe Pets Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 124. Europe Pets Anti-infective Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 125. Europe Pets Anti-infective Drugs Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 126. Europe Pets Anti-infective Drugs Market Size, by Antiparasitics, 2017-2032 (USD Million)
TABLE 127. Europe Pets Anti-infective Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 128. Europe Pets Anti-infective Drugs Market Size, by Small Mammals, 2017-2032 (USD Million)
TABLE 129. Europe Pets Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 130. Europe Pets Anti-infective Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 131. Europe Pets Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 132. Middle East Pets Anti-infective Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 133. Middle East Pets Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 134. Middle East Pets Anti-infective Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 135. Middle East Pets Anti-infective Drugs Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 136. Middle East Pets Anti-infective Drugs Market Size, by Antiparasitics, 2017-2032 (USD Million)
TABLE 137. Middle East Pets Anti-infective Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 138. Middle East Pets Anti-infective Drugs Market Size, by Small Mammals, 2017-2032 (USD Million)
TABLE 139. Middle East Pets Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 140. Middle East Pets Anti-infective Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 141. Middle East Pets Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 142. Africa Pets Anti-infective Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Africa Pets Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 144. Africa Pets Anti-infective Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 145. Africa Pets Anti-infective Drugs Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 146. Africa Pets Anti-infective Drugs Market Size, by Antiparasitics, 2017-2032 (USD Million)
TABLE 147. Africa Pets Anti-infective Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 148. Africa Pets Anti-infective Drugs Market Size, by Small Mammals, 2017-2032 (USD Million)
TABLE 149. Africa Pets Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 150. Africa Pets Anti-infective Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 151. Africa Pets Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 152. Global Pets Anti-infective Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 153. ASEAN Pets Anti-infective Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 154. ASEAN Pets Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 155. ASEAN Pets Anti-infective Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 156. ASEAN Pets Anti-infective Drugs Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 157. ASEAN Pets Anti-infective Drugs Market Size, by Antiparasitics, 2017-2032 (USD Million)
TABLE 158. ASEAN Pets Anti-infective Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 159. ASEAN Pets Anti-infective Drugs Market Size, by Small Mammals, 2017-2032 (USD Million)
TABLE 160. ASEAN Pets Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 161. ASEAN Pets Anti-infective Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 162. ASEAN Pets Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 163. GCC Pets Anti-infective Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 164. GCC Pets Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 165. GCC Pets Anti-infective Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 166. GCC Pets Anti-infective Drugs Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 167. GCC Pets Anti-infective Drugs Market Size, by Antiparasitics, 2017-2032 (USD Million)
TABLE 168. GCC Pets Anti-infective Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 169. GCC Pets Anti-infective Drugs Market Size, by Small Mammals, 2017-2032 (USD Million)
TABLE 170. GCC Pets Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 171. GCC Pets Anti-infective Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 172. GCC Pets Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 173. European Union Pets Anti-infective Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 174. European Union Pets Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 175. European Union Pets Anti-infective Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 176. European Union Pets Anti-infective Drugs Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 177. European Union Pets Anti-infective Drugs Market Size, by Antiparasitics, 2017-2032 (USD Million)
TABLE 178. European Union Pets Anti-infective Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 179. European Union Pets Anti-infective Drugs Market Size, by Small Mammals, 2017-2032 (USD Million)
TABLE 180. European Union Pets Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 181. European Union Pets Anti-infective Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 182. European Union Pets Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 183. BRICS Pets Anti-infective Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 184. BRICS Pets Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 185. BRICS Pets Anti-infective Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 186. BRICS Pets Anti-infective Drugs Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 187. BRICS Pets Anti-infective Drugs Market Size, by Antiparasitics, 2017-2032 (USD Million)
TABLE 188. BRICS Pets Anti-infective Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 189. BRICS Pets Anti-infective Drugs Market Size, by Small Mammals, 2017-2032 (USD Million)
TABLE 190. BRICS Pets Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 191. BRICS Pets Anti-infective Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 192. BRICS Pets Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 193. G7 Pets Anti-infective Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 194. G7 Pets Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 195. G7 Pets Anti-infective Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 196. G7 Pets Anti-infective Drugs Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 197. G7 Pets Anti-infective Drugs Market Size, by Antiparasitics, 2017-2032 (USD Million)
TABLE 198. G7 Pets Anti-infective Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 199. G7 Pets Anti-infective Drugs Market Size, by Small Mammals, 2017-2032 (USD Million)
TABLE 200. G7 Pets Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 201. G7 Pets Anti-infective Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 202. G7 Pets Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 203. NATO Pets Anti-infective Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 204. NATO Pets Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 205. NATO Pets Anti-infective Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 206. NATO Pets Anti-infective Drugs Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 207. NATO Pets Anti-infective Drugs Market Size, by Antiparasitics, 2017-2032 (USD Million)
TABLE 208. NATO Pets Anti-infective Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 209. NATO Pets Anti-infective Drugs Market Size, by Small Mammals, 2017-2032 (USD Million)
TABLE 210. NATO Pets Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 211. NATO Pets Anti-infective Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 212. NATO Pets Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 213. Global Pets Anti-infective Drugs Market Size, by Country, 2017-2032 (USD Million)
TABLE 214. United States Pets Anti-infective Drugs Market Size, 2017-2032 (USD Million)
TABLE 215. United States Pets Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 216. United States Pets Anti-infective Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 217. United States Pets Anti-infective Drugs Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 218. United States Pets Anti-infective Drugs Market Size, by Antiparasitics, 2017-2032 (USD Million)
TABLE 219. United States Pets Anti-infective Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 220. United States Pets Anti-infective Drugs Market Size, by Small Mammals, 2017-2032 (USD Million)
TABLE 221. United States Pets Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 222. United States Pets Anti-infective Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 223. United States Pets Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 224. Canada Pets Anti-infective Drugs Market Size, 2017-2032 (USD Million)
TABLE 225. Canada Pets Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 226. Canada Pets Anti-infective Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 227. Canada Pets Anti-infective Drugs Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 228. Canada Pets Anti-infective Drugs Market Size, by Antiparasitics, 2017-2032 (USD Million)
TABLE 229. Canada Pets Anti-infective Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 230. Canada Pets Anti-infective Drugs Market Size, by Small Mammals, 2017-2032 (USD Million)
TABLE 231. Canada Pets Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 232. Canada Pets Anti-infective Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 233. Canada Pets Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 234. Mexico Pets Anti-infective Drugs Market Size, 2017-2032 (USD Million)
TABLE 235. Mexico Pets Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 236. Mexico Pets Anti-infective Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 237. Mexico Pets Anti-infective Drugs Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 238. Mexico Pets Anti-infective Drugs Market Size, by Antiparasitics, 2017-2032 (USD Million)
TABLE 239. Mexico Pets Anti-infective Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 240. Mexico Pets Anti-infective Drugs Market Size, by Small Mammals, 2017-2032 (USD Million)
TABLE 241. Mexico Pets Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 242. Mexico Pets Anti-infective Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 243. Mexico Pets Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 244. Brazil Pets Anti-infective Drugs Market Size, 2017-2032 (USD Million)
TABLE 245. Brazil Pets Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 246. Brazil Pets Anti-infective Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 247. Brazil Pets Anti-infective Drugs Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 248. Brazil Pets Anti-infective Drugs Market Size, by Antiparasitics, 2017-2032 (USD Million)
TABLE 249. Brazil Pets Anti-infective Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 250. Brazil Pets Anti-infective Drugs Market Size, by Small Mammals, 2017-2032 (USD Million)
TABLE 251. Brazil Pets Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 252. Brazil Pets Anti-infective Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 253. Brazil Pets Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 254. United Kingdom Pets Anti-infective Drugs Market Size, 2017-2032 (USD Million)
TABLE 255. United Kingdom Pets Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 256. United Kingdom Pets Anti-infective Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 257. United Kingdom Pets Anti-infective Drugs Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 258. United Kingdom Pets Anti-infective Drugs Market Size, by Antiparasitics, 2017-2032 (USD Million)
TABLE 259. United Kingdom Pets Anti-infective Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 260. United Kingdom Pets Anti-infective Drugs Market Size, by Small Mammals, 2017-2032 (USD Million)
TABLE 261. United Kingdom Pets Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 262. United Kingdom Pets Anti-infective Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 263. United Kingdom Pets Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 264. Germany Pets Anti-infective Drugs Market Size, 2017-2032 (USD Million)
TABLE 265. Germany Pets Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 266. Germany Pets Anti-infective Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 267. Germany Pets Anti-infective Drugs Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 268. Germany Pets Anti-infective Drugs Market Size, by Antiparasitics, 2017-2032 (USD Million)
TABLE 269. Germany Pets Anti-infective Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 270. Germany Pets Anti-infective Drugs Market Size, by Small Mammals, 2017-2032 (USD Million)
TABLE 271. Germany Pets Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 272. Germany Pets Anti-infective Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 273. Germany Pets Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 274. France Pets Anti-infective Drugs Market Size, 2017-2032 (USD Million)
TABLE 275. France Pets Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 276. France Pets Anti-infective Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 277. France Pets Anti-infective Drugs Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 278. France Pets Anti-infective Drugs Market Size, by Antiparasitics, 2017-2032 (USD Million)
TABLE 279. France Pets Anti-infective Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 280. France Pets Anti-infective Drugs Market Size, by Small Mammals, 2017-2032 (USD Million)
TABLE 281. France Pets Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 282. France Pets Anti-infective Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 283. France Pets Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 284. Russia Pets Anti-infective Drugs Market Size, 2017-2032 (USD Million)
TABLE 285. Russia Pets Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 286. Russia Pets Anti-infective Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 287. Russia Pets Anti-infective Drugs Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 288. Russia Pets Anti-infective Drugs Market Size, by Antiparasitics, 2017-2032 (USD Million)
TABLE 289. Russia Pets Anti-infective Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 290. Russia Pets Anti-infective Drugs Market Size, by Small Mammals, 2017-2032 (USD Million)
TABLE 291. Russia Pets Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 292. Russia Pets Anti-infective Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 293. Russia Pets Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 294. Italy Pets Anti-infective Drugs Market Size, 2017-2032 (USD Million)
TABLE 295. Italy Pets Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 296. Italy Pets Anti-infective Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 297. Italy Pets Anti-infective Drugs Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 298. Italy Pets Anti-infective Drugs Market Size, by Antiparasitics, 2017-2032 (USD Million)
TABLE 299. Italy Pets Anti-infective Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 300. Italy Pets Anti-infective Drugs Market Size, by Small Mammals, 2017-2032 (USD Million)
TABLE 301. Italy Pets Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 302. Italy Pets Anti-infective Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 303. Italy Pets Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 304. Spain Pets Anti-infective Drugs Market Size, 2017-2032 (USD Million)
TABLE 305. Spain Pets Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 306. Spain Pets Anti-infective Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 307. Spain Pets Anti-infective Drugs Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 308. Spain Pets Anti-infective Drugs Market Size, by Antiparasitics, 2017-2032 (USD Million)
TABLE 309. Spain Pets Anti-infective Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 310. Spain Pets Anti-infective Drugs Market Size, by Small Mammals, 2017-2032 (USD Million)
TABLE 311. Spain Pets Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 312. Spain Pets Anti-infective Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 313. Spain Pets Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 314. China Pets Anti-infective Drugs Market Size, 2017-2032 (USD Million)
TABLE 315. China Pets Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 316. China Pets Anti-infective Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 317. China Pets Anti-infective Drugs Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 318. China Pets Anti-infective Drugs Market Size, by Antiparasitics, 2017-2032 (USD Million)
TABLE 319. China Pets Anti-infective Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 320. China Pets Anti-infective Drugs Market Size, by Small Mammals, 2017-2032 (USD Million)
TABLE 321. China Pets Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 322. China Pets Anti-infective Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 323. China Pets Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 324. India Pets Anti-infective Drugs Market Size, 2017-2032 (USD Million)
TABLE 325. India Pets Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 326. India Pets Anti-infective Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 327. India Pets Anti-infective Drugs Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 328. India Pets Anti-infective Drugs Market Size, by Antiparasitics, 2017-2032 (USD Million)
TABLE 329. India Pets Anti-infective Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 330. India Pets Anti-infective Drugs Market Size, by Small Mammals, 2017-2032 (USD Million)
TABLE 331. India Pets Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 332. India Pets Anti-infective Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 333. India Pets Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 334. Japan Pets Anti-infective Drugs Market Size, 2017-2032 (USD Million)
TABLE 335. Japan Pets Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 336. Japan Pets Anti-infective Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 337. Japan Pets Anti-infective Drugs Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 338. Japan Pets Anti-infective Drugs Market Size, by Antiparasitics, 2017-2032 (USD Million)
TABLE 339. Japan Pets Anti-infective Drugs Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 340. Japan Pets Anti-infective Drugs Market Size, by Small Mammals, 2017-2032 (USD Million)
TABLE 341. Japan Pets Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 342. Japan Pets Anti-infective Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 343. Japan Pets Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 344. Australia Pets Anti-infective Drugs Market Size, 2017-2032 (USD Million)
TABLE 345. Australia Pets Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 346. Australia Pets Anti-infective Drugs Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 347. Australia Pets Anti-infective Drugs Market Size, by Antifungals, 2017-2032 (USD Million)
TABLE 348. Australia Pets Anti-infective Drugs Market Size, by Antiparasitics, 2017-2032 (USD Million)
TABLE 349. Australia Pets Anti-infective Drugs Market Size, by Animal Type, 2017-2032 (US

Companies Mentioned

  • Bayer Animal Health
  • Bimeda Animal Health
  • Boehringer Ingelheim Animal Health
  • Cargill Inc.
  • Ceva Santé Animale
  • China Animal Healthcare Ltd.
  • China Animal Husbandry Industry Corporation
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Evonik Industries AG
  • Guangdong Wens Dahuanong Biotechnology Co. Ltd.
  • Hester Biosciences Ltd.
  • Huvepharma
  • IDEXX Laboratories, Inc.
  • Intas Pharmaceuticals
  • Kyoritsu Seiyaku Corporation
  • Merck Animal Health
  • Nippon Zenyaku Kogyo Co., Ltd.
  • Norbrook Laboratories
  • Nutreco N.V.
  • Phibro Animal Health Corporation
  • Prodivet Pharmaceuticals SA/NV
  • Vetoquinol S.A.
  • Virbac S.A.
  • Zoetis Inc.

Related Topics

Related Reports

Anti-infectives Market - Global Forecast 2026-2032 - Product Image

Anti-infectives Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Anti-Infective Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Anti-Infective Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Anti-Infective Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Anti-Infective Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 120 Pages
  • Global
From
Anti-infectives Market Report by Type, Route of Administration, Distribution Channel, and Region 2026-2034 - Product Image

Anti-infectives Market Report by Type, Route of Administration, Distribution Channel, and Region 2026-2034

  • Report
  • 140 Pages
  • Global
From
Anti-Infectives - Global Strategic Business Report - Product Image

Anti-Infectives - Global Strategic Business Report

  • Report
  • 158 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.